Nancy M. Wildermann, BA

The Anticoagulant Therapy with Bivalirudin to Assist in the <br />
Performance of Percutaneous Coronary Intervention in Patients with

08/01/2008

Mark A. Turco , MD, FACC;

Yoseph Shalev , MD;

Peter Ver Lee , MD;

A. Ralph Rodriguez , MD;

E. Magnus Ohman , MD;

Robert A. Harrington , MD;

Robert M. Califf , MD;

Jay H. Traverse , MD;

Kenneth W. Mahaffey , MD;

Bruce E. Lewis , MD;

Nancy M. Wildermann , BA;

Scott D. Berkowitz , MD;

Renee M. Oliverio , RN;

Heparin-induced thrombocytopenia (HIT) is infrequent and often goes unrecognized. It occurs in ~1% to 5% of the patients given unfractionated heparin,1 about 25–50% of whom will develop HIT with thrombotic syndrome (HITTS).2 Morbidity and...

Heparin-induced thrombocytopenia...

08/01/2008

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 6 ⁠–⁠ November 8

November 7 ⁠–⁠ November 10

November 8

November 8 ⁠–⁠ November 10

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

See Full Calendar

Nancy M. Wildermann, BA

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products